Drugs / Valproate acid
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02027987 | Oct 2013 → Dec 2016 | traumatic brain injury | Xijing Hospital | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT05603104 | Apr 2025 → Jun 2028 expected | bipolar depression, major depressive disorder, schizophrenia | Dr. Inge Winter | Recruiting | No outcome recorded |
| Phase 3 | NCT05973786 | Feb 2025 → Jun 2028 expected | bipolar depression | Dr. Inge Winter | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Valproate acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05973786 ↗ |
| Route | Intravenous | “by intravenous drip” NCT02027987 ↗ |